Crinetics Pharmaceuticals In shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Crinetics Pharmaceuticals In
Tip: Access up to 7 years of quarterly data
All positions including Crinetics Pharmaceuticals In held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crinetics Pharmaceuticals In by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $30M | 713k | 41.65 |
| 2025-03-31 | $17M | 500k | 33.54 |
| 2024-12-31 | $37M | 721k | 51.13 |
| 2024-09-30 | $40M | 787k | 51.10 |
| 2024-06-30 | $29M | 649k | 44.79 |
| 2024-03-31 | $40M | 864k | 46.81 |
| 2023-12-31 | $23M | 650k | 35.58 |
| 2023-09-30 | $16M | 553k | 29.74 |
| 2023-06-30 | $11M | 615k | 18.02 |
| 2023-03-31 | $8.4M | 520k | 16.06 |
| 2022-12-31 | $2.4M | 133k | 18.30 |
| 2022-06-30 | $1.8M | 98k | 18.64 |
| 2022-03-31 | $2.4M | 111k | 21.95 |
| 2021-12-31 | $1.7M | 62k | 28.41 |
| 2021-09-30 | $1.2M | 55k | 21.05 |
| 2021-03-31 | $1.9M | 122k | 15.28 |
| 2020-12-31 | $1.8M | 128k | 14.11 |
| 2020-09-30 | $1.6M | 101k | 15.67 |
| 2020-06-30 | $246k | 14k | 17.52 |
| 2019-09-30 | $1.1M | 73k | 15.05 |
| 2019-06-30 | $4.5M | 181k | 25.00 |
| 2019-03-31 | $328k | 14k | 22.79 |
| 2018-12-31 | $329k | 11k | 29.98 |